Overview
Tohru Ohmori practices in Higashiyukigaya, Japan. Ohmori is highly rated in 3 conditions, according to our data. Their top areas of expertise are EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
Their clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerOhmori isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung CancerOhmori isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Acute Interstitial PneumoniaOhmori isExperienced. Learn about Acute Interstitial Pneumonia.
- Interstitial Lung DiseaseOhmori isExperienced. Learn about Interstitial Lung Disease.
- Lung AdenocarcinomaOhmori isExperienced. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Ohmori isExperienced. Learn about Small Cell Lung Cancer (SCLC).